Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Daisuke Kashiwabara

Efficacy and Safety of Repaglinide vs Nateglinide for Treatment of Japanese Patients With Type 2 Diabetes Mellitus

Journal of Diabetes Investigation

English

Related publications

Short-Term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

Pharmacology

2019

English

State of the Art Paper the Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus

Archives of Medical Science

Medicine

2013

English

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

English

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

English

Evaluation of Efficacy and Safety of Cilnidipine and Losartan in Hypertensive Patients With Type 2 Diabetes Mellitus

International Journal of Medicine and Public Health

2016

English

Reduction in Glucose Fluctuations in Elderly Patients With Type 2 Diabetes Using Repaglinide: A Randomized Controlled Trial of Repaglinide vs . Sulfonylurea

Journal of Diabetes Investigation

English

Prevalence of Type 2 Diabetes Mellitus in Japanese Patients With Hepatocellular Carcinoma

Experimental and Therapeutic Medicine

English

“Efficacy and Safety Bariatric Surgery VS. Clinical Treatment in Control of Levels Glycemic and Remission Diabetes Mellitus Type II in Patients Obese”

English

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Daisuke Kashiwabara

Efficacy and Safety of Repaglinide vs Nateglinide for Treatment of Japanese Patients With Type 2 Diabetes Mellitus

Related publications

Short-Term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus

State of the Art Paper the Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

Evaluation of Efficacy and Safety of Cilnidipine and Losartan in Hypertensive Patients With Type 2 Diabetes Mellitus

Reduction in Glucose Fluctuations in Elderly Patients With Type 2 Diabetes Using Repaglinide: A Randomized Controlled Trial of Repaglinide vs . Sulfonylurea

Prevalence of Type 2 Diabetes Mellitus in Japanese Patients With Hepatocellular Carcinoma

“Efficacy and Safety Bariatric Surgery VS. Clinical Treatment in Control of Levels Glycemic and Remission Diabetes Mellitus Type II in Patients Obese”

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone